Novo Nordisk AS (NVO)
102.64
-2.63
(-2.50%)
USD |
NYSE |
Nov 21, 16:00
102.62
-0.02
(-0.02%)
After-Hours: 19:58
Novo Nordisk Price to Book Value: 25.26 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 25.91 |
| November 19, 2024 | 25.26 |
| November 18, 2024 | 24.57 |
| November 15, 2024 | 25.04 |
| November 14, 2024 | 25.93 |
| November 13, 2024 | 26.32 |
| November 12, 2024 | 26.35 |
| November 11, 2024 | 26.85 |
| November 08, 2024 | 26.39 |
| November 07, 2024 | 26.53 |
| November 06, 2024 | 25.97 |
| November 05, 2024 | 27.15 |
| November 04, 2024 | 27.05 |
| November 01, 2024 | 27.59 |
| October 31, 2024 | 27.60 |
| October 30, 2024 | 27.92 |
| October 29, 2024 | 27.60 |
| October 28, 2024 | 27.70 |
| October 25, 2024 | 27.95 |
| October 24, 2024 | 28.09 |
| October 23, 2024 | 28.53 |
| October 22, 2024 | 28.71 |
| October 21, 2024 | 28.93 |
| October 18, 2024 | 29.11 |
| October 17, 2024 | 29.15 |
| Date | Value |
|---|---|
| October 16, 2024 | 29.10 |
| October 15, 2024 | 29.04 |
| October 14, 2024 | 29.53 |
| October 11, 2024 | 29.59 |
| October 10, 2024 | 28.98 |
| October 09, 2024 | 28.85 |
| October 08, 2024 | 28.90 |
| October 07, 2024 | 29.04 |
| October 04, 2024 | 28.38 |
| October 03, 2024 | 28.37 |
| October 02, 2024 | 28.72 |
| October 01, 2024 | 29.10 |
| September 30, 2024 | 29.36 |
| September 27, 2024 | 33.28 |
| September 26, 2024 | 34.25 |
| September 25, 2024 | 34.98 |
| September 24, 2024 | 34.57 |
| September 23, 2024 | 34.09 |
| September 20, 2024 | 35.14 |
| September 19, 2024 | 37.17 |
| September 18, 2024 | 36.39 |
| September 17, 2024 | 36.38 |
| September 16, 2024 | 37.73 |
| September 13, 2024 | 37.76 |
| September 12, 2024 | 37.66 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
13.44
Minimum
Mar 20 2020
45.73
Maximum
Jun 25 2024
25.07
Average
23.94
Median
Price to Book Value Benchmarks
| Ascendis Pharma AS | -- |
| Amgen Inc | 20.70 |
| AstraZeneca PLC | 4.892 |
| Grifols SA | 0.9708 |
| Viking Therapeutics Inc | 6.316 |
Price to Book Value Related Metrics
| PE Ratio | 33.26 |
| PS Ratio | 11.65 |
| PEG Ratio | 1.182 |
| Price to Free Cash Flow | 46.66 |
| Price | 102.64 |
| Earnings Yield | 3.01% |
| Market Cap | 456.05B |
| PEGY Ratio | 1.127 |
| Operating PE Ratio | 26.61 |
| Normalized PE Ratio | 33.26 |